Background
Hepatocellular carcinoma (HCC) is a common malignancy in Southeast Asia. HCC and respiratory system cancers are the most common cause of cancer-related deaths in Taiwan [
1,
2]. HCC is the fourth highest cause of cancer-related death in Japan [
3] and the fifth most common cancer diagnosed in Korea [
4]. Due to better diagnosis, improvements in management, and prolonged survival of patients, an increasing number of patients are diagnosed after extrahepatic spread. The most common sites of metastases are the lungs, lymph nodes, and bones [
5]. While axial skeletal metastasis is common in HCC, initial presentation as spinal cord/root compression is extremely rare, and it may cause paralysis and bowel and bladder dysfunction. Early disease-focused treatment includes radiotherapy and surgery, which play a crucial role in decreasing spinal cord compression and improving quality of life. To the best of our knowledge, there are 33 cases published to date (Table
1). We did not find any reports of HCC presenting as spinal cord/root compression in Native Americans.
Table 1
Summary of cases of hepatoma presenting with spinal cord compression
1 | 1989 | | 57 | M | Paper from Japan | Not reported | Not reported | Paraplegia |
2–17 | 1992 | | 26–59 | M/F | n/a (paper from Taiwan) | 75% (12/16) hepatitis B positive | Not reported | - Pain/weakness in the distribution of thoracic/lumbar spine – 8 cases - Arm weakness – 2 cases - Scalp mass – 3 cases - Right hemicranias – 1 case - Diplopia – 1 case - Dysarthria – 1 case |
18 | 1993 | | 45 | M | n/a (paper from, Syracuse, NY state) | Hepatitis C, hepatitis B, and alcoholic liver disease with cirrhosis | Not reported | Low back pain |
19 | 1997 | | 37 | M | n/a (paper from Hong Kong) | Hepatitis B | Not reported | Low back pain |
20 | 1997 | | 47 | F | n/a (paper from Hong Kong) | Not reported | Not reported | Low back pain |
21 | 1998 | | 77 | M | Malay (Asian) | Alcoholic with liver cirrhosis | ALT and AST were elevated | Right lower limb weakness and paresthesia |
22 | 1998 | | 68 | M | Malay (Asian) | Not reported | Not reported | Sudden onset of lower extremities paraparesis |
23 | 2003 | | 60 | M | n/a (paper from Taiwan) | Hepatitis B and C | Remission | Low back pain |
24 | 2005 | | 49 | M | Not reported | Alcohol abuse, hepatitis B and C negative | Not reported | Low back pain |
25 | 2006 | | 55 | M | Not reported (paper from China) | Hepatitis B | Remission | Low back pain |
26 | 2006 | | 70 | M | Not reported (paper from China) | Alcoholic, hepatitis B and C negative | Not reported | Chest pain |
27 | 2006 | | 62 | M | Not reported (paper from China) | Nonalcoholic, hepatitis B and C negative | Not reported | Pain in the neck and low back |
28 | 2011 | | 50 | M | Not reported (paper from USA) | Alcohol abuse, hepatitis B | AST 146 U/L, ALT 84 U/l | Low back pain |
29 | 2014 | | 46 | M | Namibian (Africa) | Alcoholic hepatitis and hepatitis B | AST 180 IU/l and ALT 70 IU/l | b/l leg weakness |
30 | 2014 | | 79 | M | n/a (paper from Greece) | Hepatitis B (not on medications) | Not mentioned | Upper extremity muscle pain and paresthesia |
31 | 2015 | | 61 | M | n/a (paper from South Korea) | Hepatitis B | AST 418 U/l ALT 594 U/l HBV DNA 1890769 copies/mL | Upper extremity weakness and tingling |
32 | 2016 | | 49 | M | Emigrant from Ghana | Hepatitis B not on medications | ALT and AST WNL | Left lower extremity weakness and numbness |
33 | 2017 | | 58 | M | n/a (paper from Bronx, USA) | Hepatitis C and alcohol abuse | LFTs WNL | Neck pain |
34 | 2017 | Our patient | 64 | M | Native American | Hepatitis C (treated, no viral load detected) | ALT 505, AST 210, bilirubin 1.5 | Lower back pain and numbness |
35 | 2017 | Our patient | 70 | M | Native American | Hepatitis C Ab positive. RNA not detected | ALT 90, AST 104 | Upper back pain and numbness of right foot |
We report the cases of two Native American patients who presented with spinal cord compression secondary to HCC metastasis associated with hepatitis C infection. In one of these cases, the hepatitis C infection had been successfully controlled. Hepatitis C titers were undetectable for a year before the patient developed spinal cord compression. We did not find any literature reporting HCC presenting with spinal cord compression in Native Americans.
Discussion
Metastasis to the spinal cord is a very unusual and rare presentation of HCC. To the best of our knowledge, only 33 such cases have been published to date (Table
1). Of those 33 patients, 21 had evidence of previous hepatitis B infection, and two of them had hepatitis C as well. One patient was positive for hepatitis C and had a history of alcohol abuse. Three patients had a history of alcohol abuse without evidence of viral hepatitis infection. One patient who was not an alcoholic was negative for both hepatitis B and C. Data on hepatitis serologies were not available for seven of the cases. The incidence of bone metastasis varies from 1% to 20% [
7]. Due to improved diagnosis and therapeutic modalities for HCC, more cases of extrahepatic metastases, especially bone metastases, have been detected in recent years. We report two cases of Native Americans with HCC presenting with a spinal cord compression. We could not find any previous publications of HCC presenting with spinal cord compression in Native Americans. One of our cases had undetectable hepatitis C RNA levels at the time of HCC diagnosis. In another case, there were no signs of liver cirrhosis when the patient was diagnosed as having HCC.
HCC is the most common primary hepatic cancer and is an uncommon cancer in Western countries, including the USA. The overall incidence in the USA is 0.21–0.57%, but the incidence is higher in Asia and sub-Saharan Africa. In Japan, the relative frequency of HCC during autopsies is 2.57–4.8% [
7]. It ranks as the fourth highest cause of cancer-related death in Japan [
3]. The high incidence of HCC is largely driven by the high burden of hepatitis B and HCV infection in these regions [
3,
5], with hepatitis B infection being found in 75–80% of patients with HCC [
8,
9]. In the Asian population, the rate of seropositivity for hepatitis B surface antigen (HBsAg) approaches 100% in children with HCC compared with 70–80% in adults with HCC [
9].
An epidemiological study of HCC in Taiwanese children aged 6 to 14 began after the launch of a nationwide vaccination program in 1984. The average incidence of HCC declined from 0.70 per 100,000 children for the period of 1981 to 1986 to 0.36 per 100,000 children for the period of 1990 to 1994 [
9]. In many developed nations, including the USA, HCV infection accounts for more than half of HCC cases, in contrast to Asian countries [
10].
While the pathophysiology of HCC in hepatitis C or B infection is unclear, the chronic inflammatory process in the liver may play a significant role. The liver inflammatory processes stimulate growth, repair, and restoration of normal liver architecture. When liver inflammation becomes chronic, the balance of damage versus regeneration is impaired and stimulates the formation of excess fibrotic tissue. In the long term, liver inflammation leads to cirrhosis, which is characterized by abnormal liver architecture and function. Cirrhosis leads to end-stage liver disease, hepatic failure, and liver cancer [
10]. HCC can also occur in non-cirrhotic patients, particularly in patients with hepatitis B infection [
11].
The risk factors for HCC include Asian and African race, cirrhosis of the liver, and hepatitis B or C infection. HCC is one of the more aggressive neoplasms, with metastatic potential mainly targeting the lungs, lymph nodes, bone, and adrenal glands. Most patients with HCC present with hepatomegaly, right upper quadrant pain, and/or abdominal mass [
12]. While bone metastasis is reported to occur in cases of HCC, its presentation as spinal cord compression is extremely unusual [
5,
12‐
14].
In Taiwan, HCC is the fifth most frequently diagnosed cancer and second highest cause of cancer-related mortality [
15]. In the USA and other Western countries, HCC accounts for less than 2% of all neoplasms and is often related to hepatitis C infection or alcohol intake. In Asia, where hepatitis B virus is endemic, HCC is commonly associated with hepatitis B infection [
16]. In the USA, chronic HCV is the leading risk factor for HCC [
17].
According to the population-based Surveillance Epidemiology and End Results registry data, the overall HCC incidence rate is approximately 6 per 100,000 in the USA. It is more common in Asian men [
18]. However, the largest increase is occurring among Hispanics, followed by African Americans and non-Hispanic whites, with the lowest increase occurring among Asians [
17,
18]. The incidence and mortality of HCC is highest in Southern USA (that is, Texas, Louisiana, and Mississippi) [
18]. HCV infection is associated with a 15-fold to 20-fold increased risk of HCC compared with individuals who are HCV negative. Following establishment of HCV-related cirrhosis, HCC develops at an average annual rate of 1–8% [
18]. The presence of any level of HCV viremia is a strong risk factor for HCC compared to the absence of viremia [
18]. While a dose–response relationship between hepatitis C RNA level and liver cirrhosis has been reported [
19], viral load is not associated with HCC [
17]. Patients who are HCV positive with advanced fibrosis who clear viremia with antiviral treatment have a reduced, though not eliminated, risk of HCC [
17]. HCC can occur even after more than 10 years have passed since successful HCV clearance [
20]. It is suggested that HCV leads to irreversible changes in cellular signaling via mechanisms such as epigenetic activation or imprinting, which continue to drive carcinogenesis even after viral clearance [
20]. Currently, the widespread implementation of novel direct-acting antivirals, which target the viral protease, polymerase, or nonstructural proteins, achieves 90% of the sustained virologic response. However, additional large studies with long-term follow-up are required to determine the HCC incidence rate after HCV eradication. Our first case demonstrates that even with eradication of hepatitis C infection, hepatoma still developed after many months.
The incidence of HCC in Native Americans was 3.5–6.6 per 100,000 [
20], which is slightly higher than that in whites (2.6–3.5 per 100,000) and slightly lower than that in African Americans (4.2–7.0 per 100,000) and Hispanics (4.8–8.0 per 100,000) [
21]. Stewart
et al. showed that cause-specific survival in Native Americans was slightly higher (44.6 weeks, 95% confidence interval) than it was in whites (42.4 weeks, 95% confidence interval) and African Americans (36.3 weeks, 95% confidence interval) [
22]. Xu
et al. reported that in the USA, Asian patients demonstrated the highest overall survival of 15 months compared with white, black, and Native American patients who had an overall survival of 11 months, 9 months, and 12 months, respectively (all
p < 0.05) [
23].